Zofer 4mg Tablet contains Ondansetron 4mg, a selective 5-HT3 receptor antagonist used primarily for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery. Ondansetron works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting, at the 5-HT3 receptors located in the central nervous system and gastrointestinal tract. Zofer 4mg is indicated for patients undergoing emetogenic cancer treatments to improve their comfort and compliance with therapy. It is also effective in managing postoperative nausea and vomiting following surgical procedures. The tablet formulation allows for convenient oral administration, ensuring rapid absorption and onset of action. Zofer is generally well-tolerated; however, potential side effects may include headache, constipation, dizziness, and fatigue. Caution is advised in patients with a history of cardiac arrhythmias or electrolyte imbalances, as Ondansetron can cause QT interval prolongation. Dosage adjustments may be necessary in hepatic impairment. Zofer 4mg should be used under medical supervision, with adherence to prescribed dosing schedules to maximize efficacy and minimize adverse effects. It is contraindicated in patients with known hypersensitivity to Ondansetron or other components of the formulation.